Back
Supernus Pharmaceuticals Stock Price Chart
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
29
SUPN
Supernus Pharmaceuticals
Last Price:
32.11
Seasonality Move:
-9.35%
7 Day Trial
ALL ACCESS PASS
$
7
How this hedge fund manager trades weekly options
Claim your free training on trading weekly options- The current trend is relatively stagnant and SUPN is experiencing slight buying pressure.
Supernus Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 31.72 | Buy |
| 20-day SMA: | 33.48 | Sell |
| 50-day SMA: | 31.92 | Buy |
| 200-day SMA: | 29.77 | Buy |
| 8-day EMA: | 32.09 | Buy |
| 20-day EMA: | 32.66 | Sell |
| 50-day EMA: | 31.9 | Buy |
| 200-day EMA: | 30.35 | Buy |
Supernus Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.21 | Sell |
| Relative Strength Index (14 RSI): | 45.86 | Sell |
| Chaikin Money Flow: | 72355 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.23 - 35.11) | Sell |
| Bollinger Bands (100): | (27.01 - 32.71) | Buy |
Supernus Pharmaceuticals Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Supernus Pharmaceuticals Stock
Is Supernus Pharmaceuticals Stock a Buy?
- Supernus Pharmaceuticals share price is 32.12 while SUPN 8-day simple moving average is 31.72, which is a Buy signal.
- The stock price of SUPN is 32.12 while Supernus Pharmaceuticals 20-day SMA is 33.48, which makes it a Sell.
- Supernus Pharmaceuticals 50-day simple moving average is 31.92 while SUPN share price is 32.12, making it a Buy technically.
- SUPN stock price is 32.12 and Supernus Pharmaceuticals 200-day simple moving average is 29.77, creating a Buy signal.
SUPN Technical Analysis vs Fundamental Analysis
Sell
29
Supernus Pharmaceuticals (SUPN)
is a Sell
Is Supernus Pharmaceuticals a Buy or a Sell?
-
Supernus Pharmaceuticals stock is rated a Sell
The current Supernus Pharmaceuticals [SUPN] share price is $32.12. The Score for SUPN is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
Supernus Pharmaceuticals Stock Info
Market Cap:
1.77B
Price in USD:
32.12
Share Volume:
173.65K
Supernus Pharmaceuticals 52-Week Range
52-Week High:
35.44
52-Week Low:
21.99
Sell
29
Supernus Pharmaceuticals (SUPN)
is a Sell
Supernus Pharmaceuticals Share Price Forecast
-
What is the Supernus Pharmaceuticals stock price today?
The Supernus Pharmaceuticals stock price is 32.12 USD today. -
Will SUPN stock go up or go down?
Supernus Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Supernus Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Supernus Pharmaceuticals is overvalued.
Is Supernus Pharmaceuticals Stock a Buy?
- Supernus Pharmaceuticals share price is 32.12 while SUPN 8-day exponential moving average is 32.09, which is a Buy signal.
- The stock price of SUPN is 32.12 while Supernus Pharmaceuticals 20-day EMA is 32.66, which makes it a Sell.
- Supernus Pharmaceuticals 50-day exponential moving average is 31.90 while SUPN share price is 32.12, making it a Buy technically.
- SUPN stock price is 32.12 and Supernus Pharmaceuticals 200-day simple moving average is 30.35, creating a Buy signal.
Fundamental Analysis of Supernus Pharmaceuticals
Is Supernus Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.36 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and a decrease next year of $0.18 per share.
Technical Analysis of Supernus Pharmaceuticals
Should I short Supernus Pharmaceuticals stock?
- SUPN Moving Average Covergence Divergence (MACD) indicator is -0.21, suggesting Supernus Pharmaceuticals is a Sell
- Supernus Pharmaceuticals Relative Strength Index (RSI) is 45.86, which suggest Supernus Pharmaceuticals is oversold
- The Bollinger Bands (25) for Supernus Pharmaceuticals is (32.23 - 35.11), which suggest Supernus Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Supernus Pharmaceuticals is (27.01 - 32.71), which suggest Supernus Pharmaceuticals is a Buy
* Supernus Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.